SPECTRON MRC LLC FDA Approval ANDA 203911

ANDA 203911

SPECTRON MRC LLC

FDA Drug Application

Application #203911

Application Sponsors

ANDA 203911SPECTRON MRC LLC

Marketing Status

Prescription001

Application Products

001INJECTABLE;INTRAVENOUS4-500mCi/ML0FLUDEOXYGLUCOSE F18FLUDEOXYGLUCOSE F-18

FDA Submissions

UNKNOWN; ORIG1AP2015-04-22

Submissions Property Types

ORIG1Null15

CDER Filings

NUKEMED
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 203911
            [companyName] => NUKEMED
            [docInserts] => ["",""]
            [products] => [{"drugName":"FLUDEOXYGLUCOSE F18","activeIngredients":"FLUDEOXYGLUCOSE F-18","strength":"4-500mCi\/ML","dosageForm":"INJECTABLE;INTRAVENOUS","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"04\/22\/2015","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2015-04-22
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.